Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-25-000081
Filing Date
2025-08-07
Accepted
2025-08-07 16:15:59
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx-20250630.htm   iXBRL 10-Q 1475963
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3112025-06.htm EX-31.1 10345
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit3122025-06.htm EX-31.2 10289
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3212025-06.htm EX-32.1 7820
5 CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit3222025-06.htm EX-32.2 7807
  Complete submission text file 0001610618-25-000081.txt   7649808

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20250630.xsd EX-101.SCH 47198
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20250630_cal.xml EX-101.CAL 71374
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20250630_def.xml EX-101.DEF 315861
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20250630_lab.xml EX-101.LAB 684765
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20250630_pre.xml EX-101.PRE 514681
69 EXTRACTED XBRL INSTANCE DOCUMENT cdtx-20250630_htm.xml XML 924590
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 251194247
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)